Analyst Research: Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

77.36USD
1 Aug 2013
Price Change (% chg)

$-0.52 (-0.67%)
Prev Close
$77.88
Open
$79.25
Day's High
$81.75
Day's Low
$74.03
Volume
135,728
Avg. Vol
103,511
52-wk High
$86.29
52-wk Low
$11.19

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - CLOVIS ONCOLOGY INC (CLVS-O) 1 Aug 2013 Thomson Reuters Stock Report 11 25.00
ValuEngine Detailed Valuation Report for CLVS 31 Jul 2013 ValuEngine, Inc. 11 25.00
CLOVIS ONCOLOGY INC (CLVS) 12-months forecast 26 Jul 2013 Pechala's Reports 1 15.00
Clovis Oncology Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 26 Jul 2013 Reuters Investment Profile 12 20.00
CLOVIS ONCOLOGY (CLVS) Zacks Company Snapshot 22 Jul 2013 Zacks Investment Research Inc. 1 12.00
Clovis Oncology, Inc. (CLVS) - Medical Equipment - Deals and Alliances Profile 21 Jul 2013 GlobalData 24 250.00
CLOVIS ONCOLOGY (CLVS) Zacks Company Snapshot 18 Jul 2013 Zacks Investment Research Inc. 1 12.00
CLVS.OQ - Event Transcript of Clovis Oncology Inc conference call, May 15, 2013 / 1:40PM ET 15 May 2013 Thomson Reuters StreetEvents 14 75.00
 
Name Age Since Current Position

Patrick Mahaffy

49 2009 President, Chief Executive Officer, Director

Erle Mast

49 2009 Chief Financial Officer, Executive Vice President

Andrew Allen

45 2009 Executive Vice President - Clinical and Pre-Clinical Development, Chief Medical Officer

Gillian Ivers-Read

59 2009 Executive Vice President - Technical Operations, Chief Regulatory Officer

Steven Hoerter

41 2011 Senior Vice President - Commercial
Search Stocks